What these drugs seem to be doing is creating a cultural moment where consumers are thinking more about losing weight
Its regulation is also shifting, and so hunger cues are changing
Those taking 2.4 mg of semaglutide weekly had a lower risk of death from cardiovascular disease, nonfatal heart disease, and stroke compared to a placebo group over the 40 months of follow-up
In many cases, that means protein first
In one study, people who took Semaglutide GLP-1 injections along with making lifestyle changes lost an average of 15.3% of their initial body weight over 68 weeks
GLP-1 (Glucagon-Like Peptide-1) medications are a type of prescription drug that have been gaining attention in the medical community for their potential benefits in managing various health conditions, particularly for women with Polycystic Ovary Syndrome (PCOS)